- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Synonyms: AMG-162
Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.
Shimon Sakaguchi
Nature Communications 2025,16, Article number:1325
David Baker
Dev Cell 2023, 58(20):2163-2180.e9.
David Julius
Cell 2017, 185-198.e16
Michael Houghton
Cell Chem Biol, 2020, 27(7):780-792.e5
Charles M. Rice
Cell 2018, 172(3):423-438.e25
| Name | Citation | NF-κB | Others |
|---|---|---|---|
| QNZ (EVP4593) | 156 | TNF-α | |
| JSH-23 | 166 | ||
| B022 | 0 | ||
| UCB-9260 | 0 | TNF | |
| Morusin | 0 | STAT3 | |
| IQ 3 | 1 | TNF-α,IL-6,JNK3 | |
| CBL0137 | 9 | FACT,p53 | |
| NIK SMI1 | 0 | ||
| Ginsenoside Rb3 | 1 | iNOS,COX-2 | |
| Ginsenoside Rd | 4 | iNOS,COX-2,Ca2+ influx | |
| CBL0137 Hydrochloride | 9 | FACT,p53 | |
| SC75741 | 53 | ||
| TPCA-1 | 73 | STAT3,IKK2 | |
| Bardoxolone Methyl | 36 | IKK,Ferroptosis,Nrf2 | |
| Curcumin | 50 | Nrf2,Ferroptosis,HDAC | |
| Sodium 4-Aminosalicylate | 2 | ||
| Caffeic Acid Phenethyl Ester | 55 | ||
| Sodium salicylate | 1 | ||
| HOIPIN-8 | 0 | ||
| EN450 | 0 | ||
| Chitosan oligosaccharide | 0 | ||
| NF-κB-IN-1 | 2 | ||
| SM-7368 | 0 | ||
| sappanone A | 0 | ||
| Okanin | 0 | TLR4 | |
| Rubiadin 1-methyl ether | 0 | ||
| Cornuside | 0 | ||
| BTYNB | 0 | ||
| TCEP Hydrochloride | 2 | ||
| IMM-H007 | 0 | ABCA1,JNK/AP1,AMPK | |
| Urolithin B | 1 | ERK,JNK,IκBα | |
| L-Quebrachitol | 0 | Wnt/β-catenin,MAPK,Runx2 | |
| Licochalcone D | 0 | EGFR,JAK2,PARP | |
| Tectochrysin | 0 | ||
| Caulophylline (N-Methylcytisine) | 0 | IκB,MPO,IKK | |
| Myrislignan | 1 | COX-2,iNOS,TNF-α | |
| NDMC101 | 0 | ||
| Gardenoside | 0 | IL-6,IL-1β,TNF-α | |
| Cucurbitacin IIb | 0 | IκBα,ERK1/2,JNK | |
| Jaceosidin | 0 | Mcl-1,Bax,COX-2 | |
| Isoliquiritin apioside | 0 | MAPK,MMP | |
| Withaferin A (WFA) | 13 | vimentin | |
| Rocaglamide | 3 | eIF4A,HSF1 | |
| Xanthatin | 0 | STATs | |
| Alobresib (GS-5829) | 0 | MYC,ERK1/2,Akt | |
| Adjudin | 1 | ERK,Cl⁻ channel | |
| IAXO-102 | 0 | MAPK,TLR4 | |
| C25-140 | 0 | TRAF6-Ubc13 | |
| SN50 | 5 | ||
| INH14 | 0 | IKKβ,IKKα | |
| TAK-243 (MLN7243) | 74 | UAE | |
| Sulforaphane | 22 | Nrf2,HO-1,ROS | |
| Madecassic acid | 1 | IL-1β,TNF-α,COX-2 | |
| Homoplantaginin | 1 | IL-6,IKKβ,TNF-α | |
| (+)-Praeruptorin A | 0 | ||
| 2',5'-Dihydroxyacetophenone | 1 | IL-6,TNF-α,ERK1/2 | |
| Dauricine | 1 | ||
| 8-O-acetyl shanzhiside methyl ester | 0 | ||
| Forsythoside B | 0 | IκB,IL-6,TNF-alpha | |
| Engeletin | 2 | ||
| Berbamine | 8 | CaMKII,Bcr-Abl | |
| Eleutheroside E | 0 | ||
| Mulberroside A | 0 | Caspase-1,NALP3,IL-6 | |
| Maslinic acid | 1 | ||
| Chelidonic acid | 0 | glutamate decarboxylase,IL-6,Caspase-1 | |
| Hyperoside | 5 | ||
| Vanillic acid | 0 | ||
| 4'-Hydroxychalcone | 0 | ||
| (+)-α-Lipoic acid | 1 | LTR | |
| 4-Hydroxychalcone | 2 | ||
| Neferine | 5 | ||
| Benfotiamine | 1 | ||
| Ginsenoside Rb1 | 4 | IFN-β,TNF-α,TLR4 | |
| Ginsenoside Rg1 | 5 | Aβ | |
| Guaiacol | 0 | COX-2 | |
| (E)-Cardamonin | 0 | TRPA1 | |
| Hederagenin | 0 | COX-2,iNOS | |
| Ginsenoside Re | 1 | JNK,Aβ | |
| Scutellarin | 1 | Akt,STAT3 | |
| Mangiferin | 1 | Nrf2 | |
| Schisantherin A | 0 | ||
| Curcumenol | 3 | CYP3A4 | |
| Muscone | 4 | TNF-α,IL-1β,NLRP3 inflammasome | |
| Tyrosol | 0 | ||
| Stachydrine | 3 | ||
| Sodium Aescinate | 2 | ||
| Dehydroevodiamine | 0 | PGE2,iNOS,COX-2 | |
| Astragaloside IV | 3 | mTOR,Akt,ERK | |
| 4'-Methoxyresveratrol | 0 | NLRP3 | |
| Berbamine dihydrochloride | 2 | CaMKII,Bcr-Abl | |
| Sarsasapogenin | 1 | IκBα,TAK1,IRAK1 | |
| (±)-Shikonin | 41 | Proteasome,chemokine receptor,TNF-α | |
| Diethylmaleate | 0 | Nrf2 | |
| Omaveloxolone (RTA-408) | 11 | Nrf2 | |
| DTP3 | 2 | GADD45β/MKK7 | |
| APX-3330 | 5 | APE1(Ref-1) | |
| Triptolide | 47 | MDM2,HSF1 | |
| Methylthiouracil | 0 | ERK1/2,IL-6,TNF-α | |
| Erdosteine | 0 | ||
| Evodiamine | 9 | ||
| Vanillylacetone | 1 | ||
| (-)-Parthenolide | 27 | p53,MDM2,HDAC1 | |
| Magnolol | 7 | ||
| Indole-3-carbinol | 3 | ||
| DHA (Dihydroartemisinin) | 35 | ||
| Andrographolide | 11 |
| Description |
Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.
|
References |
|
|---|
| CAS No. | 615258-40-7 |
|---|---|
| Molecular Weight | 145.16 kDa |
| Isotype | human IgG1 |
| Source | HEK293 |
| Sterility | 0.2 μM filtered |
| Formulation | PBS Buffer, pH 7.4 |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.